Takasaki, Japan

Akihiro Aizawa

This inventor holds 1 USPTO granted patent. Top assignee: Japan Immunoresearch Laboratories Co., Ltd.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akihiro Aizawa. Retrieved from https://idiyas.com/inventor/akihiro-aizawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akihiro Aizawa: Innovator in Glycobiology

Introduction

Akihiro Aizawa is a notable inventor based in Takasaki, Japan. He has made significant contributions to the field of glycobiology, particularly in the area of sugar chains and their applications in medical diagnostics and treatments.

Latest Patents

Aizawa holds a patent for a sugar chain that can be prepared by separating glycoproteins from cell membrane components using lectins that recognize the sugar chain. This innovative process allows for the release and purification of the sugar chain structure from glycoproteins. The resulting sugar chain has potential applications in the diagnosis and treatment of cancer, showcasing its importance in medical research.

Career Highlights

Aizawa is associated with Japan Immunoresearch Laboratories Co., Ltd., where he continues to advance research in glycobiology. His work has garnered attention for its potential impact on cancer diagnostics and therapies.

Collaborations

Aizawa collaborates with esteemed colleagues such as Nobuo Shimoda and Masakazu Adachi, contributing to a dynamic research environment focused on innovative solutions in healthcare.

Conclusion

Akihiro Aizawa's contributions to glycobiology and his innovative patent highlight the importance of research in developing new diagnostic and therapeutic methods for cancer. His work exemplifies the intersection of science and innovation in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…